Moro O Salifu, Kevin C Abbott, Serhat Aytug, Amir Hayat, Dhiren M Haria, Syed Shah, Eli A Friedman, Barbara G Delano, Samy I McFarlane, Frank P Hurst, Peter L Flom, Rahul M Jindal
BACKGROUND: The incidence of new-onset diabetes after initiation of hemodialysis (NODAD) and its impact on survival is not known. METHODS: We used data from the United States Renal Data System (USRDS) from January 2000 to December 2001, with at least 3 years of follow-up for this study. Patients aged 18-80 years were included. NODAD was defined as two Medicare institutional claims for diabetes in patients with no history of diabetes prior to starting hemodialysis (HD)...
2010: American Journal of Nephrology